Common heartburn drugs put to test in liver disease care
NCT ID NCT07248722
Summary
This study aims to settle a medical debate about whether patients with advanced liver disease (cirrhosis) should routinely take acid-suppression drugs after a preventive procedure for swollen veins in their esophagus. Researchers will enroll 210 patients and randomly assign half to take the drugs and half not to take them, then compare rates of bleeding, side effects, and death over six weeks. The goal is to provide clearer guidance on whether the potential benefit of preventing bleeding outweighs the possible risks of infection or other complications from the acid drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, 110840, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.